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Objective: To investigate the biological function of
platelet-derived growth factor B (PDGF-B) on the survival
and proliferation of cat corneal endothelial cells so as to
provide bases for further studies of its role in wound repair
and its clinical application.
Methods: Total RNA was extracted from the placenta
tissues of healthy pregnan t women undergoing
hysterotokotomy and PDGF cDNA was obtained with re-
verse transcription-polymerasechain reaction (RT-PCR). The
prokaryotic expression vector pET-PDGF-B was constructed
and expressed the recombinant PDGF-B in Escherichia coli
(E.coli) BL21 (DE3).After purification and refolding on Ni2+-
chelation affinity chromatography(NTA) column, it was used
to culture cat corneal endothelial cells. Cell proliferation was
tested bymodified tertrazolium salt (MTT) and flowcytometer.
And the morphologic change and the ultrastructure were ob-
served under an inverted phase contrast microscope, a scan-
ning electron microscope and a transmission electon
microscope, respectively.
Results: PDGF-B chain peptide (PDGF-BB) gene was
successfully inserted into the prokaryotic expression vector,
pET-28a (+). The purified recombined protein pET-PDGF-B
showed a single band on sodium dodecyl sulfate polyacry-
lamide gel electropheresis (SDS-PAGE) with the molecular
weight of about 27 u, which was in agreement with the de-
duced value. MTT and flow cytometryshowed that PDGF-BB
promoted the survival and proliferation of cat corneal en-
dothelial cells.
Conclusions: The construction of recombinant prokary-
otic expression vector pET-PDGF-B and the preparation of
PDGF-BB protein provide a foundation for further study of
the function of PDGF-BB and producing biological PDGF-
BB protein. The expressed PDGF-BB promotes the prolif-
eration of cultured cat corneal endothelial cells.
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Platelet-derived growth factor (PDGF) was firstdiscovered by Ross et al1 in 1974 and it wasso named for it was firstly purified from platelets.
However, many other cells, such as endothelial cells,
macrophages and smooth muscle cells, are found to
produce and secrete PDGF or PDGF-like growth factors.2
The molecular weight of PDGF is about 30 000 u and is
comprised by two polypeptide chains of A and B, mainly
showingasdimersof PDGF-AA,PDGF-BB andPDGF-AB.
PDGF is a potential mitogen of many cells, including
fibroblasts, smooth muscle cells and endothelial cells.2, 3
PDGF can increase cell proliferation and differentiation
and stimulate cytoskeleton recombination.2-6 PDGF-BB
may play an important role in the mitosis and trauma
repair in corneal endothelial cells. In this study, to de-
termine the effect of PDGF-BB oncorneal endothelial cells,
prokaryoticexpressionvectorpET-PDGF-Bwasconstructed.
The recombinantPDGF-B proteinsexpressedinEscheri-
chia coli (E. coli) bacteria (strain BL21), purified and re-
folded on Ni2+- chelation affinity chromatography (NTA)
column. And then they were applied to cat corneal en-
dothelial cells cultured in vitro. The proliferation and dif-
ferentiation of the cells were studied to provide experi-
mental data for clinical application.
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METHODS
Materials
Restriction endonucleases and T4 DNA ligase were
purchased from Promega (USA). Omniscript reverse
transcriptase kits, mini-MTM DNA extraction system
and gel extraction miniprep kit were purchased from
QiagenCompany, USA. Pryobest DNA polymerase was
obtained from Takara Biotechnology Co. Ltd (Dalian,
China). Bacterial expression plasmid pET28a(+) and
E. coli bacteria (strain BL21 and strain TG1) were pre-
served in our own lab. Histidine bind kits were obtained
from Novagen Company (USA). Reagents for protein
refolding were purchased from Calbiochem (Dalian,
China). The polylysine, fetal calf serum (FCS), horse
serum and Dulbecco modified Eagle medium (DMEM)
were purchased from Gibco (USA).
Construction of pET-PDGF-B expression vector
Total human RNA was isolated from the placenta tis-
sues of healthy pregnant women undergoing
hysterotokotomy according to the instructions of Qiagen
Rneasymini kits.ThepurifiedRNAwasanalyzedbyagrose
gelelectrophoresisandquantifiedspectraphotometrically.
PDGF-B mature fragments were generated by reverse
transcription-polymerase chain reaction (RT-PCR) us-
ing upstream primers containing BamH I site and down-
stream primers containing EcoR I site. The sequences
for the forward and reverse primers were as follows (5’-
3’) : gc ggattc atg aat cgc tgc tgg gcg ctc and (5’-3’) gc
gaattc cta ggc tcc aag ggt ctc ctt, according to the
nucleic acid sequence encoding human PDGF-B re-
ported in the Genebank (NM_002608). The PDGF-B
PCR reaction mixture was firstly pre-denatured at 95°C
for 15 minutes, then amplified for 40 cycles, with one
amplification cycle consisting of denaturation for 1
minute at 94°C, primer annealing for 1 minute at 52°C,
and extension for 1 minute at 72°C. The PCR products
were cloned into plasmid pBluescript SK(+) (pBSK) vec-
tor by T4 ligase and amplified by plasmid extract kits.
After sequencing, the correct fragments were cut at the
BamH I and EcoR I sites with endonuclease and cloned
directly into the expression vector pET28a (+) under the
control of T7 promoter (Fig.1).
Expression and purification of human PDGF-B
One of our main aims of this study was to obtain
recombinant human PDGF-BB protein. E. coli bacteria
(strain BL21) were transformed with expression vector
pET28a containing mature fragments of human PDGF-
B cDNAs and grown at 37°C till an A600 being 0.8 ap-
proximately. The bacteria were induced by 1.0 mmol/L
isopropyl-beta-D-thiogalactoside (IPTG). After 5 hours,
the bacteria were harvested and the sample was soni-
cated in a tube on ice until the sample was no longer
viscous. The recombinant proteins formed inclusion
bodies and the inclusion bodies were collected and sus-
pended in 20 ml wash buffer (2 mol/L urea, 0.5 mol/L
NaCl, 10% glycerol, 1% TritonX-100, and 50 mmol/L 2-
mercaptoethanol, pH 8.2) per 100 ml culture media.
This step wasrepeated for several timesto release more
trapped proteins. The supernatant was removed from
the final centrifugation and the final pellets of purified
inclusion bodieswere dissolved in 5 ml dissolution buffer
(6 mol/Lurea, 0.5mol/L NaCl, 10% glycerol, 1% TritonX-
100, 20 mmol/L Tris, pH 10.5) per 100 ml culture media.
Sincesix consecutivehistidine residueswere expressed
at the N-terminal end of the proteins, the proteins were
purified and refolded on Ni2+-NTA column,7 namely,
single-step purification and refolding method. The dis-
solved supernatant was filtered through a 0.45-micron
membrane and then loaded onto a Ni2+-NTA column.
After washed off the protein contaminants with 10 col-
Fig. 1. Schematic representation of pBSK-PDGF-B and pET28-PDGF-B expression vector. The PDGF-B gene is ligated into pBSK and
pET28a (+) at BamH I and EcoR I sites.
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umn volume (CV) of binding buffer, 10 CV NTA-pH 6.5
buffer (6 mol/L urea, 0.5 mol/L NaCl, 10% glycerol, 1%
TritonX-100, and 20 mmol/L Tris, pH 6.5) and 10 CV
NTA-pH 5.8 buffer (6 mol/L urea, 0.5 mol/L NaCl, 10%
glycerol, 1% TritonX-100, and 20 mmol/L Tris, pH 5.8),
the refolding process was performed on Ni2+-NTA col-
umn directly. The refolding process was started with 10
CV Buffer A (4 mol/L urea, 0.5 mol/L NaCl, 6% glycerol,
20 mmol/L Tris, and 2 mmol/L GSH, pH 8.0), then 5
CV Buffer B (2 mol/L urea, 0.5 mol/L NaCl, 3% glycerol,
20 mmol/L Tris, 2 mmol/L GSH, and 0.2 mmol/L GSSG,
pH 8.0) and 10 CV Buffer C (0.5 mol/L NaCl, 20 mmol/L
Tris, 2 mmol/L GSH, and 0.5 mmol/L GSSG, pH 8.0)
followed.At last, renatured proteinwaseluted withBuffer
D (300 mmol/L imidazole and 0.5 mol/L NaCl, pH 8.0).
The purity of the recombinant proteins was determined
by sodium dodecyl sulfate polyacrylamide gel
electropheresis (SDS-PAGE). Protein concentration
was determined by protein-dye binding (Bio-Rad).
Primary culture of cat corneal endothelial cells
Cats were anesthetized excessively by Chloral Hy-
drate and fresh cat eyes were moved out and immersed
in D-Hanks solution containing 100 U/ ml penicillin and
100 µg/ml streptomycin for 30 minutes and then rinsed
with sterile water. The corneas were excised under ster-
ile conditions and placed in a petri dish containing
DMEM. Under a dissecting microscope, the membrane
of the posterior elastic layer with the attached endothe-
lium was stripped from the stroma and placed in a 15-
ml centrifuge tube containing 0.25% trypsin. The tis-
sues were incubated for 10 minutes at 37°C and then
the cells were detached by vigorous disruption with a
flame-polished pipette. The cells were centrifugated
(1000 r/min) and resuspended in culture medium of
DMEM containing 0.5% fetal bovine serum. Then the
cells were incubated in tissue culture bottles at 37°C in
a 5% CO2 humidified atmosphere. The medium was
changed every other day. The cells reached confluence
in 10-14 days. The cat endothelial cells by monolayer
culture were harvested with 0.05% trypsin/0.02%
ethylenediaminetetraacetic acid (EDTA) solution.
Immunocytochemical staining of cat corneal en-
dothelial cells
Neurone specific enolase (NSE) is a specific marker
protein of cat corneal endothelium, which could effec-
tively distinguish endothelial cells and keratocytes. In
this study, immunocytochemical staining with anti-NSE
antibodies was performed to identify the corneal endot-
helial cells. Briefly, 1×104 cells grewin thechamber slides
(Nalge Nunc International, Rochester, NewYork, USA),
which were fixed with4% paraformaldehyde, rinsed with
phosphatebufferedsaline (PBS) andpermeabilizedwith
ice-cold acetone. Non-specific binding was blocked
through incubating the cells in 1% bovine serum albu-
min (BSA) for 30 minutes at room temperature. For
visualizationof NSE,anti-NSE antibodies (1:250 inPBS,
Invitrogen Molecular Probes, USA) were added and the
cells were incubated overnight at 4°C and then rinsed
by PBS. Then second antibody (biotinylated goat anti-
rabbit IgG) was added and the cells were incubated for
1 hour at room temperature and rinsed by PBS for 4
times.Avidin-biotin-peroxidasecomplex (ABC) elitewas
added and the cells were incubated for 30 minutes and
rinsed by PBS for 3 times. Diaminobenzidine (DAB)
was added to develop the coloring for 5-10 minutes.
After rinsed by double distilled water(ddH2O) for 3 times,
the cells were then cover-slipped with Geltol (Thermo
Electron Corp, Waltham, MA, USA) as a mounting
media and observed under the inverted phase contrast
microscope.
Biological activity assay
The cells of 1×104-1×105 innumber were suspended
in 0.2 ml DMEM containing 0.5% fetal bovine serum
and subcultured into 96-well tissue culture plates at
37°C in a 5% CO2 humidified atmosphere. The biologi-
cal activities of PDGF-BB were determined based on
the fact that it can promote the differentiation and prolif-
eration of cat corneal endothelial cells. Modified
tertrozalium salt (MTT) method was used to assay the
proliferation of cells. About 24 hours later, the medium
was discarded and conditional media were added in
various groups after cell attachment. In details, at 37°C
in a 5% CO2 humidified atmosphere, cat corneal endot-
helial cells in the control group were cultured in DMEM,
while the cells in the experimental groups were exposed
to DMEM plus 1,10, 25, 50, 75, and 100 ng/ml PDGF-
B, respectively. Seven days later, the effects of PDGF-
BB on cell survival and proliferation were determined by
MTT and flow cytometric analysis. For MTT assay, the
cells were transferred to 20 µl MTT solution (5 mg/ml)
at 37°C in a 5% CO2 humidified atmosphere. And 4
hours later, the solution was discarded and 150 µl dim-
ethyl sulfoxide(DMSO) was added in each well. After
being shaked in a micro-blender for 10 minutes, the
optical density (OD) value was detected in 490 nm.
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Then the growth conditions of the cells were observed
under the invertedphasecontrastmicroscopeperiodically.
Flow cytometric analysis of cell proliferation
About 1×105 corneal endothelial cells treated with
or without 100 ng/ml recombinant PDGF-B for 7 days
were collected with Puck’s EDTA at 37°C and then
washed inPBS containing1mmol/LEDTA(PBS/EDTA).
The cells were fixed in 700µl high grade Ethanol (EtOH,
100%) at -20°C and the tube was inverted for several
times to ensure mixing properly and a good fixing of
the cells. Then the cells were washed for 2-3 times
with PBS/EDTA, resuspended in 1 ml DNA staining
solution (2.5 µg/ml propidium iodide and 0.5 mg/ml
RNase A in PBS), put into 5 ml fluorescence activated
cell sorting (FACS) tubes, and finally analyzed with a
FACScan flow cytometer (Becton, Dickinson and
Company, USA).
RESULTS
Construction of expression plasmid of human
PDGF-B pronucleus
In this study, we successfully isolated PDGF-B
cDNAfrom human placenta by RT-PCR. The sequence
of the amplif ied PDGF-B was confirmed by DNA
sequencing, which was identical with the human PDGF-
B described in the Genebank (NM_002608). The RT-
PCR product and a part of sequencing map of PDGF-B
are shown in Fig.2. Mature fragments were cloned into
the expression vectors, constructing the PDGF-B ex-
pression plasmid pET-PDGF-B under the control of T7
promoter.
Expression,purification andrefolding ofpET-PDGF-B
One major aim of this study was to produce recom-
binant PDGF-B proteins in prokaryote E. coli bacteria.
We transformed theexpression vector pET28a contain-
ing fragments of PDGF-B cDNAs into E. coli bacteria
(strain BL21). Recombinant PDGF-B proteins were
expressed at levels about 21.5% of total bacteria pro-
teins by gel scanning. SDS-PAGE analysis revealed
that recombinant proteins displayed a molecular weight
of about 27 u (Fig. 3), which in general agreed with the
deduced values. These results indicated that the re-
combinant proteins were correctly synthesized. Ni2+-
NTA was sufficient to purify the recombinant proteins.
In the refolding process, we found that the standard
dialysis and dilution refolding procedures after inclu-
sion body solubilization had many defects, such as
long-time requirements, too many steps, inability to re-
move denaturing agents, and low refolding efficiency.
Therefore, we used a system that allowed a faster puri-
ficationand, ideally, that would facilitate the renaturation.
A single-step refolding method was designed on Ni2+-
NTA column with Sepharose NTA-Ni2+ superflow as the
chromatographic matrix.8 An oligo-histidine domain
fused to the N- or C-terminus of a recombinant protein
overexpressed in E. coli has been reported to facilitate
the purification of the studied protein by metalchelate
chromatography.8 The purification was based on the af-
finity interaction between the oligo-histidine domain and
the free ligand binding sites of an immobilized transi-
tion metal ion. This affinity interaction was also reported
to be very strong under a variety of chemical conditions,
allowing purification under denaturing conditions and
development of a matrix-assisted renaturation.9 The
advanced refolding method took less time, fewer steps
and produced higher quantities of fully-renatured pro-
teins than standard dialysis and dilution renaturation
procedures. After purification and refolding on Ni2+-NTA
column, PDGF-B had a purity of about 90%. But this
advanced method relied ona presumption that the prop-
erly-folded form of a protein was thermodynamically or
at least kinetically more stable compared with its un-
folded or misfolded forms.
Immunocytochemical staining of cat corneal en-
dothelium
In order to identify the primarily cultured cells being
corneal endothelial cells, immunocytochemical stain-
ing of NSE was performed. NSE is the specific marker
protein of cat corneal endothelium, which can effec-
tively distinguish endothelial cells and keratocytes.10
Fig. 2. Gel electrophoresis of RT-PCR products. 1:PCR marker; 2,
3: PDGF-B cDNA.
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Corneal endothelial cells could keep expressing NSE
even after passaging for 20 times, while keratocytes
never expressed NSE. With NSE staining,buffy
macrobeads could be found in the cytoplasm of cor-
neal endothelial cells with over 98% positive rate, while
NSE staining was negative in keratocytes in the control
group (Fig. 4).
Biological activities of expressed PDGF-B
The other major aim of this study was to examine
the bioactivity of the expressed products in the trans-
fected cat endothelial cells. The effects of recombinant
PDGF-B in promoting the survival and proliferation of
cat endothelial cells were tested by MTT and flow
cytomytric assay. The MTT results showed that 75 ng/ml
recombinant PDGF-B could obviously promote the sur-
vival of cat endothelial cells7daysafter culture (P<0.05 as
compared with the controls), and the effects of 100 ng/
ml PDGF-B on endothelial cells were more significant
(P<0.01 as compared with the controls, Figs. 5 and 6).
Cell proliferation was tested by flow cytometry. Cor-
neal endothelial cells were treated with 100 ng/ml re-
combinant PDGF-B and DMEM for 7 days in the ex-
perimental groups, while in the control group no PDGF-
B was used. The results of flow cytometry showed that
PDGF-B could significantly enhance the proliferation of
corneal endothelial cells, and G2/M phase cells were
increased from 10.82% in the control group to 47.05%
in the PDGF-B group (P<0.001, Fig. 7).
DISCUSSION
Corneal endothelium is essential for the mainte-
nance of normal corneal hydration, thickness, and
transparency.11,12 Despite the critical importance of this
cell layer, a number of studies have shown that human
corneal endothelial cells do not divide at a rate suffi-
cient to maintain a constant density and that endothe-
lial cell density tends to decrease with the increasing
ages and after ocular insults.13,14 A disorder in the cor-
neal endothelium caused by diseases or traumas can
result in hydration of the stroma components and thus
induce the onset of edema. In response to an injury,
the endothelial cells may migrate into the wound site
to establish partial tight junctions before the reestab-
lishment of pump function and the restoration of cor-
neal clarity. In human beings, corneal endothelium ap-
pears to heal primarily by enlargement and migration,
not by proliferation of the endothelial cell layer.14-16
However, decompensation appears when the density
of the corneal endothelial cells is lower than 25%-45%
of the normal ones.
Althoughcorneal transplantation is aneffective treat-
ment method for dysfunctional corneal endothelium, a
few problems still remain with this approach. The pri-
mary one is the limited donorcorneas for transplantation.
Endothelial cell replacement may eliminate some of
these problems by using tissue cultured cells as the
donor source.Although many attempts havebeen made
to establish tissue-cultured models in recent years, the
establishment of pure and long-term cultured human
corneal endothelial cells from adult donors hasremained
a challenging problem. Existing culture methods require
young donors17,18 or special selection procedures to re-
move the contaminated fibroblasts.19
In this study, we established monolayer cat cor-
neal endothelial cells in relatively shorter timeand higher
cell density through applying recombinant PDGF-B to
promoting the mitogenic activity. At the same time,
methodof tearing the decemets’membrane established
the primary cultures of cat corneal endothelial cells,
which were free of contaminating fibroblasts. Cats were
used because they mimiced more closely as the hu-
man beings in having little or no mitotic activity and a
limited regenerative capacity compared with the highly-
proliferative bovine and rabbit corneal endothelial cells.20
In a word, we successfully constructed prokaryotic
expression vector pET-PDGF-B and purified and rena-
tured the recombinant PDGF-B protein and made it ex-
press inE.coli bacteria (strainBL21), thenapplied PDGF-
B to promote the proliferation and differentiation of cat
Fig 3. SDS-PAGE of recombinant human PDGF-B. 1: Bacterial total
proteins after induction; 2: Bacterial total proteins before induction;
3: Protein molecular weight marker; 4: Purified PDGF-B protein.
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corneal endothelial cells in vitro. The results of our study
provide a foundation for biologically producing PDGF-B
protein and further studying its function in reconstruction
and trauma repair of human corneal endothelial cells.
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